Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dermamist 10% spray
1302010N0BFAAAC
|
Dermamist | Paraffin soft white | Skin | 56 |
|
Isotretinoin 40mg capsules
1306020J0AAAEAE
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 55 |
|
Glycopyrronium bromide 2% in Cetomacrogol cream (Formula A)
1312000G0AABGBG
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 54 |
|
Hydrex pink chlorhexidine gluconate 0.5% solution
1311020L0BNADAL
|
Hydrex | Chlorhexidine gluconate | Skin | 54 |
|
MooGoo Scalp cream
131500000BBNEA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 54 |
|
Dithranol 0.5% cream
1305020F0AADADA
|
Dithranol (Topical) | Dithranol | Skin | 53 |
|
Freederm 4% gel
1306010N0BDAAAA
|
Freederm | Nicotinamide | Skin | 53 |
|
Povidone-Iodine 10% alcoholic solution
1311040K0AAAFAF
|
Povidone-Iodine (Topical Disinfectant/Cleanser) | Iodine compounds | Skin | 53 |
|
TCP antiseptic liquid
1311050V0BBAAAA
|
TCP (Topical) | Halogenated phenols with phenol | Skin | 52 |
|
Lotil cream
130201000BBCFA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 51 |
|
Sprilon aerosol spray
1302020D0BGABAG
|
Sprilon | Dimeticone (Barrier) | Skin | 51 |
|
Coal tar soln 6% / Salicylic acid 2% oint in a base
1305020C0AAFPFP
|
Coal tar/tar (Topical) | Tars | Skin | 49 |
|
Glycopyrronium bromide 0.05% topical solution
1312000G0AABCBC
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 49 |
|
Hydrocortisone 0.1% topical emulsion
1304000W0AABDBD
|
Hydrocortisone butyrate | Hydrocortisone butyrate | Skin | 49 |
|
Dalbecal 50micrograms/g / 0.5mg/g ointment
1305020D0BGAAAF
|
Dalbecal | Calcipotriol | Skin | 48 |
|
Diflucortolone 0.1% cream
1304000L0AAAAAA
|
Diflucortolone valerate | Diflucortolone valerate | Skin | 48 |
|
Bascellex 50mg/g cream 250mg sachets
1307000V0BDAAAA
|
Bascellex | Imiquimod | Skin | 47 |
|
Benzoyl peroxide 4% cream
1306010C0AABABA
|
Benzoyl peroxide | Benzoyl peroxide | Skin | 47 |
|
Avoca 75% silver nitrate applicators
1307000Q0BBADAC
|
Avoca | Silver nitrate | Skin | 44 |
|
Diflucortolone 0.3% oily cream
1304000L0AAACAC
|
Diflucortolone valerate | Diflucortolone valerate | Skin | 44 |
|
Isotretinoin 0.05% / Erythromycin 2% gel
1306010I0AAACAC
|
Erythromycin (Topical) | Erythromycin | Skin | 44 |
|
Pevaryl 1% cream
1310020J0BCAAAA
|
Pevaryl | Econazole nitrate | Skin | 44 |
|
Alitretinoin 30mg capsules
1305010AFAAABAB
|
Alitretinoin (Eczema) | Alitretinoin | Skin | 43 |
|
Diflucortolone 0.1% oily cream
1304000L0AAABAB
|
Diflucortolone valerate | Diflucortolone valerate | Skin | 43 |
|
Dithrocream 0.5% cream
1305020F0BIADDA
|
Dithrocream | Dithranol | Skin | 43 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.